Collegium Pharmaceutical Inc (COLL) Company Profile & Statistics

Collegium Pharmaceutical Inc
COLL
(Nasdaq - US)
N/A
37.04
-0.47 (-1.25%)
in:usd•As of: May 06, 2024 15:59 UTC -4
Open
37.67
High
37.89
Low
36.92

About Collegium Pharmaceutical Inc

CEO

Joseph Ciaffoni

Headquarters

100 technology center drive

stoughton, ma 02072, united states

Auditor

Deloitte & Touche LLP

Employees

197

Share Holders

Website

www.collegiumpharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Collegium Pharmaceutical Inc Statistics

Valuation Measures

Market Capitalization ²	1.21B
Enterprise Value	1.64B
Enterprise Value/EBITDA (ttm)	5.21
Price to Earnings Ratio (ttm)	7.55
Price to Book (mrq)	6.26
Price to Sales (ttm)	2.16
Price to Cash (ytd)	3.48

Profitability

Gross Margin (ttm)	57.47%
Operating Margin (ttm)	35.76%
Profit Margin (ttm)	8.50%
Return on Equity (ttm)	107.39%
Return on Invested Capital (ttm)	7.11%
Return on Assets (ttm)	17.07%

Income Statement

Revenue (ttm)	566.77M
Revenue Per Share (ttm)	17.73
Gross Profit (ttm)	326.17M
EBITDA (ttm)³	314.98M
Net Income Avi to Common (ttm)	48.16M
Diluted EPS (ttm)	1.18

Share Statistics

Beta (5Y Monthly)	1.06
52-Week Change	58.16%
S&P500 52-Week Change	27.73%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	31.96M
Dividend Yield	0.00%
Float ⁴	31.40M
% Held by Insiders	3.98%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	310.55M
Total Cash Per Share (mrq)	9.72
Total Debt (mrq)	667.17M
Total Debt/Equity (mrq)	341.38%
Current Ratio (mrq)	1.17%
Quick Ratio (mrq)	1.10%
Book Value Per Share (mrq)	6.13

Cash Flow

Operating Cash Flow Per Share (ytd)	6.57
Free Cash Flow (ytd)	274.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Collegium Pharmaceutical Inc

Trade With A Regulated Broker